Drug Shortage Report for ZESTORETIC
Report ID | 211672 |
Drug Identification Number | 02045737 |
Brand name | ZESTORETIC |
Common or Proper name | ZESTORETIC |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LISINOPRIL |
Strength(s) | 12.5MG 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 Tablets |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | 2024-01-01 |
Actual start date | |
Estimated end date | 2024-01-22 |
Actual end date | 2024-01-22 |
Shortage status | Resolved |
Updated date | 2024-01-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-01-23 | English | Compare |
v5 | 2024-01-22 | French | Compare |
v4 | 2024-01-22 | English | Compare |
v3 | 2024-01-02 | English | Compare |
v2 | 2023-11-28 | French | Compare |
v1 | 2023-11-28 | English | Compare |
Showing 1 to 6 of 6